Will the 2016 election decide the future of MedTech?

The fight over Obamacare is not over yet. While Republicans are vociferously campaigning for getting their own President in the office to get rid of the health care law, the Supreme Court has once again been a savior of the Affordable Care Act (ACA).

The recent Supreme Court ruling has helped clear the air to a large extent for Obamacare. While there is still room for challengers to oppose the verdict, this decision undoubtedly has given a firm basis to the ACA. “Five years ago, after nearly a century of talk, decades of trying, a year of bipartisan debate, we finally declared that in America, health care is not a privilege for a few but a right for all,” Obama said from the White House following the Supreme Court verdict.

In this conflicting political climate, it’s important to dwell on some of the key facts under Obama’s proposed agenda for the 2016 budget declared in early February. The President wished to repeal the long-debated automatic and harmful spending cuts known as sequestration by cutting inefficient spending and closing tax loopholes. He also put forward his idea of a more sustainable growth path by achieving $1.8 trillion in deficit reduction, primarily from reforms in health programs, tax code and immigration.

The President’s budget 2016 proposed robust investments in research and development (R&D) to encourage the creation of new products, capabilities and industries needed for sustainable economic growth. The budget has allotted $31.3 billion to the National Institutes of Health (NIH) to support biomedical research, a $1 billion increase over 2015 funding.

Zacks Investment Research

Zacks Investment Research

Zacks Investment Research is characterized by a team of experts who are passionate about your investing success and is focused on sharing the same reliable investment research they would want for themselves.

You May Also Like